核转运蛋白α2在胶质瘤中的表达及对其生物学行为的影响

doi:10.6040/j.issn.1671-7554.0.2018.049

摘要/Abstract

摘要： 目的探讨核转运蛋白α2(KPNA2)在胶质瘤中的表达与临床意义以及KPNA2对胶质瘤细胞生物学活性的影响。方法收集脑星形胶质细胞瘤Ⅱ、Ⅲ、Ⅳ级各30例,癌周相对正常脑组织15例,qRT-PCR及免疫组化分析KPNA2的表达;制备KPNA2干扰质粒,并以慢病毒为载体转染进入胶质瘤细胞系U87、U251,CCK8、EdU法检测KPNA2敲除后对细胞增殖的影响,Transwell小室法检测KPNA2对胶质瘤细胞迁移和侵袭的影响。结果 KPAN2在胶质瘤中表达升高,表达量与胶质瘤WHO分级呈正相关(r_s=0.559, P<0.001),与患者预后呈负相关(总生存率: χ2=21.39, P<0.001;无进展生存率: χ2=8.057, P=0.004)。KPNA2敲除后胶质瘤细胞系的增殖、迁移和侵袭能力均明显减弱。结论 KPNA2在胶质瘤的发生发展中具有重要作用,可能成为新的临床诊治的标记物和治疗靶点。

关键词: 核转运蛋白α2, 胶质瘤, 临床病理特征, 预后, 细胞增殖

Abstract: Objective To explore the clinical significance and biological effects of karyopherin α2(KPNA2)on glioma. Methods A total of 90 specimens of cerebral astrocytoma were collected, including WHO grades Ⅱ, Ⅲ and Ⅳ(30 cases for each grade), and 15 normal peritumoral tissues served as controls. The expression of KPNA2 was detected with qRT-PCR and immunohistochemistry. After that, the lentiviruses expressing small hairpin RNAs(shRNAs)of KPNA2 were introduced into the U87 and U251 glioma cells. The effects of KPNA2-knockdown on the proliferation of glioma cells were detected with CCK8 and EdU, and the effects on the cell migration and invasion were assessed with Transwell assay. Results KPAN2 was overexpressed in glioma tissues, and high level of KPNA2 was positively correlated with the WHO classification of glioma(r_s=0.559, P<0.001)and negatively correlated with the prognosis of patients(overall survival: χ2=21.39, P<0.001; relapse-free survival: χ2=8.057, P=0.004). In addition, KPNA2-knockdown significantly weakened the proliferation, migration and invasion of glioma cell lines U87 and U251. Conclusion KPNA2 plays an important role in the tumorigenesis and development of glioma and may serve as a novel biomarker or therapeutic target for clinical diagnosis and treatment.

Key words: Karyopherin α2, Glioma, Clinicopathologic features, Prognosis, Cell proliferation

中图分类号:

R574

李杰,何东,张睿,杨帆,冯少滨,杨依航,辛涛. 核转运蛋白α2在胶质瘤中的表达及对其生物学行为的影响[J]. 山东大学学报 (医学版), 2018, 56(12): 47-54.

LI Jie, HE Dong, ZHANG Rui, YANG Fan, FENG Shaobin, YANG Yihang, XIN Tao. Expression of karyopherin α2 and its effect on the biological behaviors of glioma[J]. Journal of Shandong University (Health Sciences), 2018, 56(12): 47-54.

参考文献

[1] Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820.
[2] Wang Y, Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management[J]. Cancer Lett, 2013, 331(2): 139-146.
[3] Louis DN, Pomeroy SL, Cairncross JG. Focus on central nervous system neoplasia[J]. Cancer Cell, 2002, 1(2): 125-128.
[4] 杜少静, 贺慧颖. 核转运蛋白KPNA2与肿瘤关系的研究进展[J]. 中国肿瘤临床, 2016, 43(17): 780-784. DU Shaojing, HE Huiying. Research progress on the relationship between KPNA2 and tumors[J]. Chinese Journal of Clinical Oncology, 2016, 43(17): 780-784.
[5] Tan S, Ding K, Li R, et al. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2[J]. Breast Cancer Res, 2014, 16(2): R40. doi: 10.1186/bcr3644.
[6] Mortezavi A, Hermanns T, Seifert HH, et al. KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy[J]. Clin Cancer Res, 2011, 17(5): 1111-1121.
[7] Huang L, Wang HY, Li JD, et al. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a[J]. Cell Death Dis, 2013, 4: e745. doi: 10.1038/cddis.2013.256.
[8] Hu ZY, Yuan SX, Yang Y, et al. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2014, 33(1): 61. doi: 10.1186/s13046-014-0061-1.
[9] 史本涛, 苏博兴, 方冬, 等. RNAi沉默KPNA2对人膀胱癌细胞系5637转移潜能的影响[J]. 中华肿瘤防治杂志, 2015, 22(11): 832-835. SHI Bentao, SU Boxing, FANG Dong, et al. effects of KPNA2 small interfering RNA on migration and invasion of human bladder cancer cell lines 5637[J]. Chinese Journal of Cancer Prevention and Treatment, 2015, 22(11): 832-835.
[10] Fuller GN, Scheithauer BW. The 2007 revised world health organization(WHO)classification of tumours of the central nervous system: newly codified entities[J]. Brain Pathol, 2010, 17(3): 304-307.
[11] Stewart M. Molecular mechanism of the nuclear protein import cycle[J]. Nat Rev Mol Cell Biol, 2007, 8(3): 195-208.
[12] Goldfarb DS, Corbett AH, Mason DA, et al. Importin alpha: a multipurpose nuclear-transport receptor[J]. Trends Cell Biol, 2004, 14(9): 505-514.
[13] Radu A, Blobel G, Moore MS. Identification of a protein complex that is required for nuclear protein import and mediates docking of import substrate to distinct nucleoporins[J]. Proc Natl Acad Sci USA, 1995, 92(5): 1769-1773.
[14] Görlich D, Henklein P, Laskey RA, et al. A 41 amino acid motif in importin-alpha confers binding to importin-beta and hence transit into the nucleus[J]. EMBO J, 1996, 15(8): 1810-1817.
[15] Weis K, Mattaj IW, Lamond AI. Identification of hSRP1 alpha as a functional receptor for nuclear localization sequences[J]. Science, 1995, 268(5213): 1049-1053.
[16] Weis K, Ryder U, Lamond AI. The conserved amino-terminal domain of hSRP1 alpha is essential for nuclear protein import[J]. Embo J, 1996, 15(8): 1818.
[17] Pj VDW, Chi A, Stelma T, et al. Targeting the nuclear import receptor, Kpnβ1 as an anti-cancer therapeutic[J]. Mol Cancer Ther, 2016, 15(4): 560-573.
[18] Yang J, Lu C, Wei J, et al. Inhibition of KPNA4 attenuates prostate cancer metastasis[J]. Oncogene, 2017, 36(20): 2868-2878.
[19] Shigeyasu K, Okugawa Y, Toden S, et al. Exportin-5 functions as an oncogene and a potential therapeutic target in colorectal cancer[J]. Clin Cancer Res, 2016, 23(5): 1312-1322.
[20] Jensen JB, Munksgaard PP, Sørensen CM, et al. High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy[J]. Eur Urol, 2011, 59(5): 841-848.
[21] Dankof A, Fritzsche FR, Dahl E, et al. KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ[J]. Virchows Arch, 2007, 451(5): 877-881.
[22] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646.
[23] Christiansen A, Dyrskjøt L. The functional role of the novel biomarker karyopherin α 2(KPNA2)in cancer[J]. Cancer Lett, 2013, 331(1): 18-23.
[24] Grupp K, Boumesli R, Tsourlakis MC, et al. The prognostic impact of high Nijmegen breakage syndrome(NBS1)gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression[J]. Int J Cancer, 2014, 135(6): 1399-1407.
[25] Tseng SF, Chang CY, Wu KJ, et al. Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1[J]. J Biol Chem, 2005, 280(47): 39594-39600.
[26] Thakur S, Zhang HB, Peng Y, et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal[J]. Mol Cell Biol, 1997, 17(1):444-452.
[27] Umegaki N, Tamai K, Nakano H, et al. Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1[J]. J Invest Dermatol, 2007, 127(6): 1456-1464.
[28] Ly-Huynh JD, Lieu KG, Major AT, et al. Importin alpha2-interacting proteins with nuclear roles during mammalian spermatogenesis[J]. Biol Reprod, 2011, 85(6): 1191-1202.
[29] Zhang C, Kallakury BV, Ross JS, et al. The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence[J]. Int J Cancer, 2013, 133(1): 31-42.
[30] Tan S, Ding K, Li R, et al. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2[J]. Breast Cancer Res, 2014, 16(2): R40. doi: 10.1186/bcr3644.
[31] Lu Y, Xiao L, Liu Y, et al. MIR517C inhibits autophagy and the epithelial-to-mesenchymal(-like)transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation[J]. Autophagy, 2015, 11(12): 2213-2232.
[32] Dang CV. MYC on the Path to Cancer[J]. Cell, 2012, 149(1): 22.
[33] Denechaud PD, Fajas L, Giralt A. E2F1, a novel regulator of metabolism[J]. Front Endocrinol(Lausanne), 2017,8:311. doi: 10.3389/fendo.2017.00311.

相关文章 15

[1]	王琳琳孙美丽孙玉萍张楠刘传勇. 中心体α-微管蛋白、γ-微管蛋白在脑胶质瘤中的表达及其与Survivin表达的相关性研究[J]. 山东大学学报(医学版), 2209, 47(6): 103-.
[2]	李梓绮,魏闫若雪,刘晓晗,刘春铖,赵然,刘玉昆. 长链非编码RNA HEATR3反义RNA 1参与结直肠癌发生发展的功能及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(9): 108-115.
[3]	刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74.
[4]	王磊,常霄,王梓萌,李娇娇,崔书君,杨飞,朱月香. 瘤内及瘤周DCE-MRI影像组学对宫颈癌患者无进展生存期的预测价值[J]. 山东大学学报 (医学版), 2025, 63(6): 45-54.
[5]	贾若曦,吕丽,刘涵云,吴寅平,李凤彩,赵泽华,王凯,范玉琛. 血细胞计数相关标志物对慢加急性乙型肝炎肝衰竭患者28天预后的诊断价值[J]. 山东大学学报 (医学版), 2025, 63(6): 89-99.
[6]	杜雪,李春霞,刘云霞,张涛. 基于MFPC-Cox的结直肠癌患者预后动态预测模型[J]. 山东大学学报 (医学版), 2025, 63(5): 101-110.
[7]	杨卫芳,徐宏,刘元涛,赵蕙琛. 促甲状腺激素受体抗体在Graves病复发中的作用机制及其临床意义[J]. 山东大学学报 (医学版), 2025, 63(4): 116-121.
[8]	刘文钊,张远,马湘萍,魏峰涛,卜培莉. 内皮活化和应激指数预测值与心力衰竭患者死亡风险的关联[J]. 山东大学学报 (医学版), 2025, 63(11): 27-35.
[9]	陈文亮,王欢欢,郝金锦,弓蕊,赵强,张飞,高磊,董静逊. lncRNA PVT1表达在胃癌预后评估及恶性进展中的作用:基于列线图模型与细胞功能实验的研究[J]. 山东大学学报 (医学版), 2025, 63(10): 61-71.
[10]	郭姝画,樊扬,田风,王传新,杜鲁涛,李培龙,郭兴,徐硕. 微原纤维相关蛋白3在调控胶质瘤干细胞间充质表型转化中的作用[J]. 山东大学学报 (医学版), 2024, 62(6): 9-16.
[11]	魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[12]	刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[13]	杨雪彦,吴寅平,吕丽,赵泽华,马行宇,李凤彩,王凯,范玉琛. 单核细胞与淋巴细胞比值动态变化对慢加急性乙型肝炎肝衰竭预后的诊断价值[J]. 山东大学学报 (医学版), 2024, 62(3): 61-69.
[14]	刁玉洁,林琳,李文瑄,王洲洋,江蓓,胡迎迎,刘广义. NPR预测ANCA相关血管炎不良肾脏预后及其协同多因素优化模型[J]. 山东大学学报 (医学版), 2024, 62(2): 60-68.
[15]	宋兆录,董正璇,彭传真,黄彩娜,胡克清,黄永胜,阎磊. 肾透明细胞癌中预后相关RNA编辑位点的筛选[J]. 山东大学学报 (医学版), 2023, 61(9): 69-78.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed